Title of Invention	PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER
Abstract	A personal care composition is provided which includes a trihydroxy and quaternary ammonium substituted dipropyl ether. The substituted dipropyl ether functions as a humectant when applied to skin to moisturize both in high and low relative humidity environments.

Full Text

J9002/C FORM - 2 THE PATENTS ACT, 1970 (39 of 1970) & The Patents Rules, 2003 COMPLETE SPECIFICATION (See Section 10 and Rufe 13) PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India The following specification particularly describes the invention and the manner in which it is to be performed WO 2007/101527 PCT/EP2007/001297 PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER BACKGROUND OF THE INVENTION 5 The invention concerns personal care compositions providing moisturization both in high and low relative humidity environments. Dry skin is a problem in varying degree to most humans. This condition is particularly evident in winter. Personal care products such as skin creams/lotions, shampoos/conditioners, toilette 10 bars/shower gels and antiperspirant/deodorants are normally formulated with at least one material to address dry skin. Symptoms such as itching, flaking and a visually displeasing ' dermal appearance can all to some extend be modulated. There are three classes of materials employed against the problem. Oclusive such as 15 petrolatum or silicone oils serve to inhibit loss of natural moisture. They form a barrier between the epidermis and the environment Another approach is the use of keratofytic agents to enhance rate of dermal exfoliation. Alpha-hydroxy acids are the most common agents for achieving exfoliation. 20 A third approach to dry skin is topical application of humectants. Hydroxylated monomeric and polymeric organic substances are generally used for this purpose. Glycerin known also as glycerol is one of the most effective humectants. There are several shortcomings in Hie performance of known humectants. Even the best such 25 as glycerin requires to be formulated at relatively high levels to achieve good moisturization. Secondly, known humectants perform well in high relative humidity environments; however, hardly any of these substances provide effectiveness at low relative humidity (i.e. less than 20% moisture at 20°C). Average indoor relative humidity during winter is approximately 13% in areas such as the Northeast U.S. It is quite evident that a real need exists for an improved 30 moisturization technology. A moisturizer known as Honeyquat 50 with INCI name of Hydroxypropyltrimonium Honey has been reported to be a better humectant than glycerin {see the Arch/Brooks brochure titled "Cosmetic Ingredients & Ideas®", Issue No. 2, August 2001). Honeyquat 50 is described as 35 being derived from the reaction of pendent hydroxy! groups (on the disaccharide) of a "light" deodorized grade of honey with a chlorohydroxytrimethylammonium derivative. Although this l WO 2007/101527 PCT/EP2007/001297 substance has excellent humectency, moisturization at low relative humidity still remains to be conquered. Accordingly, the present invention seeks to identify humectants which are operative not only at 5 high but also low relative humidity, for application in personal care products. SUMMARY OF THE INVENTION A personal care composition is provided which includes: (i) from about 0.0000001 to about 10% by weight of a quatemized ammonium trihydroxy 10 dipropyl ether selected from the group consisting of formula (I), (I!) and mixtures thereof. wherein R is the same or different C1-3 alkyl or hydroxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion; and 5 (ii) a cosmetically acceptable carrier. DETAILED DESCRIPTION OF THE INVENTION Now it has been found that dipropyl ethers substituted with a quaternary ammonium and three hydroxyl groups are excellent moisturizers providing humectancy in both high and low relative 0 humidity environments. These mono-ethers have the structural formula (I) and (II): wherein R is the same or different C1-3 alkyl or hydroxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion. Ordinarily the C1-3alky! constituent on the quatemized ammonium group will be methyl, ethyl, n- 25 propyl, isopropyl or hydroxyethyl and mixtures thereof. Particularly preferred is a trimethyl ammonium group known through INCI nomenclature as a "trimonium" group. Any anion can be used in the quaternary ammonium salt. The anion may be organic or inorganic with the proviso 2 WO 2007/3 01527 PCT/EP2007;001297 that the material is cosmetically acceptable. Typical inorganic anions are halides, sulfates, phosphates, nitrates and borates. Most preferred are the halides, especially chloride. Organic anionic counter ions include methosulfate, toluoyl sulfate, acetate, citrate, tartrate, lactate, gluconate and benzenesulfonate. Amounts of these dipropyl ethers may range from about 0.0000001 to about 10%, preferably from about 0.00001 to about 8%, more preferably from about 0.0001 to about 5%, still more preferably from about 0.001 to about 3%, even more preferably from about 0.1 to about 1% by weight of the composition. 10 Synthesis of the preferred dipropyl ethers (V) and (VI) is achieved by any of the synthetic methods described below: 1) reaction of 2,3-dihydroxypropyl trimethylammonium chloride (111) with 1-chloro-2,3- dihydroxypropane (IV) in the presence of aqueous sodium hydroxide (aq. NaOH) 15 (Scheme I); 2) treatment of 2,3-dihydroxypropyl trimethylammonium chloride (III) with sodium hydride (NaH) in N,N-dimethylformamide (DMF) or 1-methyl-2-pyrrolidinone (NMP), followed by addition of 1-chloro-2,3-dihydroxypropane (IV) (Scheme II); 3) reaction of 2,3-dihydroxypropyl trimethylammonium chioride (111) with 4-chIoromethyl- 20 2,2-dimethyl-1,3-dioxoIane (VII) in aqueous basic media, followed by acidification (Scheme III); 4) treatment of 2,2-dimethy1-4-hydroxymethy-1,3-dioxolane (VIII) with sodium hydride in N,N-dimethyiformamide or 1-methyl-2-pyrroIidinone, followed by addition of 1,3- dichloro-2-propanol (IX) and final addition of trimethylamine (X) (Scheme IV). The 25 reaction schemes for the synthetic methods described above are shown below. Scheme 3 WO 2007/101527 PCT/EP2007/001297 Scheme II Thus, the present invention also provides new materials as identified by structures (V) and (VI) and a process of manufacture as reported above. The process in its general form reacts 1- chloro-2,3-dihydroxypropane with 2,3-dihydroxypropyl-1-tri(C1-3) ammonium salt in a relative 10 molar ratio ranging from about 3:1 to about 1:3, preferably about 1:1. The reaction is run in the 4 WO 2007/101527 PCT/EP2007/001297 presence of an alkali material which may be sodium hydroxide, potassium hydroxide, lithium hydroxide, calcium oxide, calcium hydroxide or sodium carbonate. The reaction can be run in a protic or an aprotic medium. Preferably the medium is protic, especially water. Nonetheless, other useful solvents include diethylether, tetrahydrofuran, ethanol, methanol, N,N-5 dimethylformamide, 1-methyf-2-pyrrolidinone and any mixtures thereof. Alternatively the reaction may be run neat without any solvent. Process temperatures may range from 5°C to 200°C, with preference given over the range 20°C to 50°C. Advantageously, compositions of the present invention may also include 2,3-dihydroxypropyl 10 tri(C1-3 alkyl or hydroxyalkyl) ammonium salts, the alkyl and salt corresponding to R and X of formula (I) and/or (II). Most preferred for the aforementioned non-ether quaternary ammonium salt is 2,3-dihydroxypropyl trimethyl ammonium chloride. When the dipropyl ether and non-ether quaternary ammonium salts are formulated together, they may be present in a weight ratio ranging from about 1:1 to about 1:10000, preferably from about 1:10 to about 1:5000, 15 more preferably from about 1:100 to about 1:1000. By the term personal care composition is meant any substance applied to a human body for improving appearance, cleansing, odor control or general aesthetics. Non-limiting examples of personal care compositions include leave-on skin lotions and creams, shampoos, hair 20 conditioners, shower gels, toilet bars, antiperspirants, deodorants, dental products, shave creams, depilatories, lipsticks, foundations, mascara, sunless tanners and sunscreen lotions. Compositions of this invention will also include a cosmetically acceptable carrier. Amounts of the earner may range from about 1 to about 99.9%, preferably from about 70 to about 95%, 25 optimally from about 80 to about 90% by weight of the composition. Among the useful carriers are water, emollients, fatty acids, fatty alcohols, thickeners and combinations thereof. The carrier may be aqueous, anhydrous or an emulsion. Preferably the compositions are aqueous, especially water and oil emulsions of the W/O or O/W or triplex W/O/W variety. Water when present may be in amounts ranging from about 5 to about 95%, preferably from about 20 to 30 about 70%, optimally from about 35 to about 60% by weight Emollient materials may serve as cosmetically acceptable carriers. These may be in the form of silicone oils, natural or synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from about 0.1 to about 95%, preferably between about 1 and about 50% by 35 weight of the composition. 5 WO 2007/101527 PCTVEP2007/001297 Silicone oils may be divided into the volatile and non-volatile variety. The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms. 5 Non-volatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 x 10"6 to 0.1 m2/s at 25°C. Among the preferred nonvolatile emollients useful in the 10 present compositions are the polydimethyl siloxanes having viscosities from about 1x10-5 to about 4x10-4m2/s at 25°C. Another class of non-voiatile silicones includes emulsifying and non-emulsifying silicone elastomers. Representative of this category is dimethicone/vinyi dimethicone crosspolymer 15 (available as Dow Coming 9040, General Electric SFE 839, and Shin-Etsu KSG-18). Silicone waxes such as Siiwax WS-L (dimethicone copolyol laurate) may also be useful. Among the ester emollients are: 20 a) Alky! esters of saturated fatty acids having 10 to 24 carbon atoms, eamptes of which include behenyl neopentanoate, isononyl isonanonoate, isopropyl myristate and octyl stearate; b) Ether-esters such as fatty acid esters of ethoxylated saturated fatty alcohols; c) Polyhydric alcohol esters, such as ethylene glycol mono and di-fatty acid esters, 25 diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono¬ stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, 30 polyoxyethylene polyol fatty acid ester, sorb/tan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters, in particular pentaerythritol, trimethylolpropane and neopentyl glycol esters of C1-C30 alcohols; d) Wax esters such as beeswax, spermaceti wax and tribehenin wax; and e) Sugar ester of fatty acids such as sucrose polybehenate and sucrose 35 polycottonseedate. 6 WO 2007/101527 PCT/EP2007/001297 Natural ester emollients principally are based upon mono-, di- and tri-glycerides. Representative glycerides include sunflower seed oil, cottonseed oil, borage oil, borage seed oil. primrose oil, castor and hydrogenated castor oils, rice bran oil, soybean oil, olive oil, safflower oil, shea butter, jojoba oil and combinations thereof. Animal derived emollients are 5 represented by lanolin oil and lanolin derivatives. Amounts of the natural esters may range from about 0.1 to about 20% by weight of the compositions. Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C11-C13 isoparaffins, polybutenes, and especially isohexadecane (available commercially as 10 Permethyl 101Afrom Presperse Inc). Fatty acids having from 10 to 30 carbon atoms may also be suitable as cosmetically acceptable earners. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, linolenic, hydroxystearic and behenic acids. 15 Fatty alcohols having from 10 to 30 carbon atoms are another useful category of cosmetically acceptable carrier. Illustrative of this category are stearyl alcohol, lauryl alcohol, myristyl alcohol, oleyl alcohol and cetyl alcohol. 20 Thickeners can be utilized as part of the cosmetically acceptable carrier of compositions according to the present invention. Typical thickeners include crosslinked acrylates (e.g. Carbopol 982®), hydrophobic lly-modified acrylates (e.g. Carbopol 1382®), polyacrylamides (e.g. Sepigel 305®), acryloylmethylpropane sulfonic acid/salt polymers and copolymers (e.g. Aristoflex HMB® and AVC®), cellulosic derivatives and natural gums. Among useful cellulosic 25 derivatives are sodium carboxymethylcellulose, hydroxypropyl methocellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenan, pectin and combinations of these gums. Inorganics may also be utilized as thickeners, particularly clays such as bentonftes and hectorites, fumed silicas, talc, calcium carbonate and silicates such as 30 magnesium aluminum silicate (Veegum®). Amounts of the thickener may range from 0.0001 to 10%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight of the composition. Adjunct humectants may be employed in the present invention. These are generally polyhydric alcohol-type materials. Typical polyhydric alcohols include glycerol, propylene glycol, 35 dipropylene glycol, polypropylene glycol, polyethylene glycol, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, 7 WO 2007/101527 PCT/EP2007/001297 propoxylated glycerol and mixtures thereof. The amount of adjunct humectant may range anywhere from 0.5 to 50%, preferably between 1 and 15% by weight of the composition. Personal care compositions of the present invention may be in any form. These forms may 5 include lotions, creams, roll-on formulations, sticks, mousses, aerosol and non-aerosol sprays and fabric (e.g. non-woven textile) applied formulations. Surfactants may also be present in the compositions of the present invention. The total concentration of the surfactant when present may range from about 0.1 to about 90%, 10 preferably from about 1 to about 40%, optimally from about 1 to about 20% by weight of the composition, and being highly dependent upon the type of personal care product. The surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic surfactants are those with a C10-20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene 15 oxide per mole of hydrophobe; C2-10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di- C8--20 fatty acids; and potyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e.g. methyl gluconamides) and trialkylamine oxides are also suitable nonionic surfactants. 20 Preferred anionic surfactants include soap, alky) ether sulfates and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-20 acyl isethionates, C8-20 alkyl ether phosphates, CB-20sarcosinates, CB-20acyl lactylates, sulfoacetates and combinations thereof. 25 Useful amphoteric surfactants include cocoamidopropyl betaine, G,2-2otriaIkyl betaines, sodium lauroamphoacetate and sodium laurodiamphoacetate. Sunscreen agents may also be included in compositions of the present invention. Particularly 30 preferred are such materials as ethylhexyl p-methoxycinnamate (available as Parsol MCX®), avobenzene (available as Parsol 1789®) and benzophenone-3 (also known as oxybenzone). Inorganic sunscreen actives may be employed such as microfine titanium dioxide and zinc oxide. Amounts of the sunscreen agents when present may generally range from 0.1 to 30%, preferably from 2 to 20%, optimally from 4 to 10% by weight of the composition. 35 Antiperspirants and deodorant compositions of the present invention ordinarily will contain astringent actives. Examples include aluminum chloride, aluminum chlorhydrex, aluminum- 8 WO 2007/101527 PCT/EP2007/001297 zirconium chlomydrex glycine, aluminum sulfate, zinc sulfate, zirconium and aluminum chlorohydroglycinate, zirconium hydroxychloride, zirconium and aluminum lactate, zinc phenolsulfonate and combinations thereof. Amounts of the astringents may range anywhere from about 0.5 to about 50% by weight of the composition. 5 Dental products formulated according to the present invention will generally contain a fluoride source to prevent dental caries. Typical anti-caries actives include sodium fluoride, stannous fluoride and sodium monofluoro phosphate. Amounts of these materials will be determined by the amount of fluoride releasable which should range between about 500 to about 8800 ppm of 10 the composition. Other components of dentifrices can include desensitizing agents such as potassium nitrate and strontium nitrate, sweeteners such as sodium saccharine, aspartame, sucralose, and potassium acesulfam. Thickeners, opacifying agents, abrasives and colorants will normally also be present. 15 Preservatives can desirably be incorporated into the personal care compositions of this invention to protect against the growth of potentially harmful microorganisms. Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, dimethyloldimethylhydantoin, ethylenediaminetetraacetic acid salts (EDTA), sodium dehydroacetate, methylchloroisothiazolinone, methylisothiazolinone, iodopropynbutylcarbamate 20 and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients. Preservatives are preferably employed in amounts ranging from 0.01 % to 2% by weight of the composition. 25 Compositions of the present invention may include vitamins. Illustrative vitamins are vitamin A (retinol), vitamin B2, vitamin B3 (niacinamide), vitamin B6, vitamin C, vitamin E, folic acid and biotin. Derivatives of the vitamins may also be employed. For instance, vitamin C derivatives include ascorbyl tetraisopalmitate, magnesium ascorbyl phosphate and ascorbyl glycoside. Derivatives of vitamin E include tocopheryl acetate, tocopheryl palmitate and tocopheryl 30 linoleate. DL-pantheno! and derivatives may also be employed. For the purposes of this invention, vitamins where present are not considered as unsaturated materials. The total amount of vitamins when present in compositions according to the present invention may range from 0.001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight of the composition. 9 WO 2007/101527 PCT/EP2007/001297 Another type of useful substance can be that of an enzyme such as amylases, oxidases, proteases, lipases and combinations. Particularly preferred is superoxide dismutase (commercially available as Biocell SOD from the Brooks Company, USA). 5 Skin lightening compounds may be included in the compositions of the invention. Illustrative substances are placental extract, lactic acid, niacinamide, arbutin, kojic acid, ferulic acid, resorcinol and derivatives including 4-substituted resorcinols and combinations thereof. Amounts of these agents may range from about 0.1 to about 10%, preferably from about 0.5 to about 2% by weight of the composition. 10 Desquamation promoters may be present Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids. The term "acid" is meant to include not only the free acid but also salts and C1-30 alkyl or aryl esters thereof and lactones generated from removal of water to form cyclic or linear lactone structures. Representative acids are glycolic, lactic and malic 15 acids. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from about 0.01 to about 15% by weight of the composition. A variety of herbal extracts may optionally be included in compositions of this invention. The extracts may either be water soluble or water-insoluble earned in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents. Illustrative 20 extracts include those from green tea, chamomile, licorice, aloe vera, grape seed, citrus unshui, willow bark, sage, thyme and rosemary. Also included may be such materials as lipoic acid, retinoxytrimethylsilane (available from Clariant Corp. under the Silcare 1M-75 trademark), dehydroepiandrosterone (DHEA) and 25 combinations thereof. Ceramides (including Ceramide 1, Ceramide 3, Ceramide 3B and Ceramide 6) as well as pseudoceramides may also be useful. Amounts of these materials may range from about 0.000001 to about 10%, preferably from about 0.0001 to about 1% by weight of the composition. 30 Colorants, opacifiers and abrasives may also be included in compositions of the present invention. Each of these substances may range from about 0.05 to about 5%, preferably between 0.1 and 3% by weight of the composition. The compositions of the present invention can also be, optionally, incorporated into an insoluble 35 substrate for application to the skin such as in the form of a treated wipe. 10 WO 2007/101527 PCT7EP2007/001297 A wide variety of packaging can be employed to store and deliver the personal care compositions. Packaging is often dependent upon the type of personal care end-use. For instance, leave-on skin lotions and creams, shampoos, conditioners and shower gels generally employ plastic containers with an opening at a dispensing end covered by a closure. Typical 5 closures are screw-caps, non-aerosol pumps and flip-top hinged lids. Packaging for antiperspirants, deodorants and depilatories may involve a container with a roll-on ball on a dispensing end. Alternatively these types of personal care products may be delivered in a stick composition formulation in a container with propel-repel mechanism where the stick moves on a platform towards a dispensing orifice. Metallic cans pressurized by a propellant and having a 10 spray nozzle serve as packaging for antiperspirants, shave creams and other personal care products. Toilette bars may have packaging constituted by a cellulosic or plastic wrapper or within a cardboard box or even encompassed by a shrink wrap plastic film. The term "comprising" is meant not to be limiting to any subsequently stated elements but 15 rather to encompass non-specified elements of major or minor functional importance. In other words the listed steps, elements or options need not be exhaustive. Whenever the words "including" or "having" are used, these terms are meant to be equivalent to "comprising" as defined above. 20 Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word "about". Ail documents referred to herein, including all patents, patent applications, and printed 25 publications, are hereby incorporated by reference in their entirety in this disclosure. The following examples will more fully illustrate the embodiments of this invention. AH parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated. 30 EXAMPLE 1a This example reports the synthesis of 1-trimethylammonium-2,5,6-trihydroxydipropyl ether chloride and 1-trimethylammonium-2-hydroxymethyl-4,5-dihydroxypropyl ethyl ether chloride. To a solution of 2,3-dihydroxypropyl trimethylammonium chloride (500mg, 2.95mmol) in 35 aqueous sodium hydroxide (2.95ml, 2.95mmol) was added 1-chloro-2,3-dihydroxypropane (247uL, 2.95mmol). The resultant solution was stirred at room temperature until the pH decreased to 11 WO 2007/101527 PCT/EP2007/001297 reduced pressure at 50°C yielding a heterogeneous colorless syrup. Filtration through glass wool affords an isomeric mixture of 1-trimethylammonium-2,5,6-trihydroxydipropyl ether chloride and 1-trimethylammonium-2-hydroxymethyl-4,5-dihydroxypropy1 ethyl ether chloride as a homogeneous syrup. 5 EXAMPLE 1b This example reports the synthesis of 1-trimethylammonium-2,5,6-trihydroxydipropy1 ether chloride and 1-trimethylammoniun-2-ydroxymethyM1-4,5-dihydroxypropyl ethyl ether chloride. 2,3-Dihydroxypropyl trimethylammonium chloride (500mgt 2.95mmol) is added to a suspension 10 of sodium hydride (2.95mmol) in N,N-dimethylformamide or 1-methyl-2-pyrrolidone (3-10ml) and the resulting mixture stirred at room temperature until gas evolution ceases. This mixture is then added to 1-chloro-2,3-dihydroxypropane (247ul_, 2.95mmol) and the resultant mixture stirred at room temperature until the pH decreases to 15 ether. Removal of the water under reduced pressure at 50°C, followed by filtration through glass wool affords an isomeric mixture of 1-trimethyiammonium-2,5,6-trihydroxydipropyl ether chloride and 1-trimethylammonium-2-hydroxymethyl-4,5-dihydroxypropyl ethyl ether chloride as a homogeneous syrup. 20 EXAMPLE 1c This example reports the synthesis of 1-trimethylammonium-2,5,6- trihydroxydipropyl ether chloride and 1-trimethy1ammonium-2-hydroxymethyI-4l5-dihydroxypropyl ethyl ether chloride. To a solution of 2,3-dihydroxypropyl trimethylammonium chloride (500mg, 2.95mmol) in aqueous sodium hydroxide (2.95ml, 2.95mmol) is added 4-chloromethyl-2l2-dimethyl-1,3- 25 dioxolane (418ul, 2.95mmol). The resultant solution is stirred at room temperature until the pH decreases to 30 trimethylammonium-2-hydroxymethyW,5-dihydroxypropyl ethyl ether chloride as a homogeneous syrup. EXAMPLE 1d This example reports the synthesis of 1-trimethylammonium-2,5,6-trihydroxydipropyi ether 35 chloride. 2,2-Dimethyl-4-hydroxymethy1-1,3-dioxoIane (367ul, 2.95mmol) is added to a suspension of sodium hydride (2.95mmol) in N.N-dimethylformamide or 1-methyl-2-pyrrolidone 12 WO 2007/101527 PCT/EP2007/001297 (3-10ml) and the resulting mixture stirred at room temperature until gas evolution ceases. This mixture is then added to 1,3-chtoro-2-propanol (281 uL, 2.95mmol) and the resultant mixture stirred at room temperature until the pH decreases to EXAMPLE 2 10 A representative personal care composttion of the present invention in the form of a cosmetic lotion is outlined under table I.' TABLE I INGREDIENT WEIGHT % PHASE A Water Balance Disodium EDTA 0.05 Methyl paraben 0.15 Magnesium aluminum silicate 0.60 Triethanolamine 1.20 Quatemized ammonium trihydroxy dipropylether salt of example 1c 1.00 PHASEB Xanthan gum 0.20 NatrosoI®250HHR (ethyl cellulose) 0.50 Butyfene glycol 3.00 Glycerin 2.00 PHASEC Sodium stearoyl lactylate 0.10 Glycerol monostearate 1.50 Stearyl alcohol 1.50 Isostearyl palmitate 3.00 Silicone fluid 1.00 Cholesterol 0.25 Sorbitan stea rate 1.00 Butylated hydroxy toluene 0.05 Vitamin E acetate 0.01 13 WO 2007/101527 PCT/EP2007/001297 PEG-100stearate 2.00 Stearic acid 3.00 Propyl paraben 0.10 Parsol MCX® 2.00 Caprylic/capric triglyceride 0.50 Hydroxycaprylic acid 0.01 C12-15 Alkyl octanoate 3.00 PHASED Vitamin A palmitate 0.10 Bisabolol 0.01 Vitamin A acetate 0.01 Fragrance 0.03 Retinol 50C 0.02 Conjugated linoieic acid 0.50 EXAMPLE 3 A water-in-oil topical liquid make-up foundation according to invention is described in table II below. TABLE II INGREDIENT WEIGHT % PHASE A Cyclomethicone 9.25 Oleyl oleate 2.00 Dimethicone copolyol 20.00 PHASE B Talc 3.38 Pigment (iron oxides) 10.51 Spheron L-1500 (silica) 0.50 PHASEC Synthetic wax Durachem 0602 0.10 Arachidyl behenate 0.30 PHASE D Cyclomethicone 1.00 Trihydroxystearin 0.30 14 WO 2007/101527 PCT/EP20O7/0O1297 Quatemized ammonium trihydroxy dipropylether salt of example 1a 0.10 Disodium EDTA 0.10 Glydant Plus" 0.10 PEG-100stearate 0.10 Stearic acid 0.10 Purified water Balance Isohexadecane (Presperse Incorporated, South PJainfield, NJ) 2 Polyacrylamide and C13-14 isoparaffin and Laureth-7 (Seppic Corporation, Fairfield. NJ) 3 Dimethicone and dimethiconol (Dow Coming Corporation, Midland, Ml) 4 Sorbitan monostearate and sucrococoate (ICI Americas Incorporated, Wilmington, DE) 5 Sucrose ester of fatty add 6 DMDM hydantoin and iodopropynyl butylcarbamate (Lonza Incorporated, Fairiawn, NJ) 10 EXAMPLE 5 Illustrative of another cosmetic composition incorporating a dipropyl ether salt according to the present invention is the formula of table IV. TABLE IV INGREDIENT WEIGHT % Polysilicone-11 29 Cyclomethicone 59 Petrolatum 11 Quatemized ammonium trihydroxy dipropylether salt of example 1a 0.2 Dimethicone copolyol 0.3 Sunflowerseed oil 0.5 EXAMPLE 6 15 A relatively anhydrous composition incorporating a dipropyl ether salt of the present invention is reported in table V. TABLE V INGREDIENT WEIGHT % Cyclomethicone 80.65 Dimethicone 9.60 Squalane 6.00 I so stearic acid 1.90 16 WO 2007/101527 PCT/EP2007/001297 Borage seed oil 0.90 Quatemized ammonium trihydroxy dipropylether salt of example 1 b 0.50 Retiny! palmitate 0.25 Ceramide 6 0.10 Tocopherol 0.10 EXAMPLE 7 An aerosol packaged foaming cleanser with a dipropyl ether salt suitable for the present invention is outlined in table VI. TABLE VI INGREDIENT WEIGHT % Sunflower seed oil 20.00 Maleated soybean oil 5.00 Silicone urethane 1.00 PoIyglycero-4 oleate 1.00 Sodium C14-16 olefin sulfonate 15.00 Sodium lauryl ether sulphate (25% active) 15.00 Cocoamidopropylbetaine 15.00 DC 1784® (silicone emulsion 50%) 5.00 Polyquatemium-11 1.00 Quatemized ammonium trihydroxy dipropylether satt of example 1 b 1.00 Water Balance EXAMPLE 8 A disposable, single use personal care towelette product is described according to the present 10 invention. A 70/30 polyester/rayon non-woven towelette is prepared with a weight of 1.8 grams and dimensions of 15 cm by 20 cm. Onto this towelette is impregnated a composition with a dipropyl ether salt as outlined in table Vll below. TABLE VII INGREDIENT WEIGHT % 2,3-Dihydroxy trimethyl ammonium chloride 5.00 Glycerin 2.00 Hexylene glycol 2.00 Disodium capryl amphodiacetate 1.00 17 WO 2007/101527 PCT/EP2007/001297 Gluconolactone 0.90 Silicone microemulsion 0.85 Witch hazel 0.50 PEG-40 hydrogenated castor oil 0.50 Fragrance (terpenoid mixture) 0.20 Quatemized ammonium trihydroxy dipropylether salt of example 1c 0.05 Vitamin E acetate 0.001 Water Balance EXAMPLE 9 A toilette bar illustrative of the present invention is outlined under table Vlll. 5 TABLE Vlll INGREDIENT WEIGHT % Sodium Soap (85/15 tallow/coconut) 77.77 Quatemized ammonium trihydroxy dipropylether salt of example 1a 3.50 Glycerin 2.50 Sodium chloride 0.77 Titanium dioxide 0.40 Fragrance 1.50 Disodium EDTA 0.02 Sodium etidronate 0.02 Fluorescer 0.024 Water Balance EXAMPLE 10 A shampoo composition useful in the context of the present invention is described in table IX below. TABLE IX Ingredient Weight % Ammonium laureth sulfate 12.00 Ammonium lauryl sulfate 2.00 Cocoa midopropyl betaine 2.00 Sodium lauroamphoacetate 2.00 2,3-Dihydroxypropy! trimethyl ammonium chloride 1.50 18 WO 2007/101527 PCT/EP2007/001297 Ethylene glycol distearate 1.50 Cocomonoethanolamide 0.80 Cetyl alcohol 0.60 Polyquatemium-10 O.50 Quatemized ammonium trihydroxy dipropylether salt of example 1a 0.50 Dimethicone 1.00 Zinc pyridinethione 1.00 Sodium citrate 0.40 Citric acid 0.39 Sodium xylene sulfonate 1.00 Fragrance 0.40 Sodium benzoate 0.25 Kathon CG® 0.0008 Benzyl alcohol 0.0225 Water Balance EXAMPLE 11 This example illustrates an antiperspirant/deodorant formula incorporating the moisturizing actives according to the present invention. TABLEX Ingredient Weight % Cyclopentacycloxane 44 Dimethicone 20 Aluminum zirconium trichlorohydrex glycinate 15 Quatemized ammonium trihydroxy dipropylether salt of example 1 c 5.0 C18-C36 acid triglyceride 5.0 Microcrystalline wax 3.0 Glycerin 3.0 Silica 2.5 Dimethicone crosspolyrner 1.0 Fragrance 0.5 Disodium EDTA 0.4 Butylated hydroxytoluene 0.3 Citric acid 0.3 19 WO 2007/101527 PCT/EP2007/001297 EXAMPLE 12 A toothpaste according to the present invention can be formulated with the ingredients listed under table XI. TABLE XI Ingredients Weight % Zeodent115® 20.00 Glycerin 18.00 Xanthan gum 7,00 Sodium carboxymethyl cellulose 0.50 Sodium bicarbonate 2.50 Quatemized ammonium trihydroxy dipropylether salt of example 1 a 2.00 Sodium laurylsulfate 1.50 Sodium fluoride 1.10 Sodium saccharin 0.40 Titanium dioxide 1.00 PluronicF-127® 2.00 FD&CblueNo. 1 3.30 Menthol 0.80 Potassium nitrate 5.00 Water balance EXAMPLE 13 A moisturizing oil-in-water lotion can be formulated with the ingredients listed under table XII. 10 TABLE XII INGREDIENT WEIGHT % Water Balance Quaternary ammonium trihydroxydipropylether salt of example 1 c 0.5 Glycerin 5.00 Disodium EDTA 0.1 Methyl paraben 0.1 Niacinamide 0.5 Triethanoiamine 0.25 D-Pantheno! 0.1 Sodium dehydroacetate 0.1 20 WO 2007/101527 PCT/EP20O7/OO1297 Benzyl alcohol 0.25 GLW75CAP-MP1 0.5 Hexamidine disethionate 0.1 Palmitoyl-penta peptide2 0.0003 N-Acetyl glucosamine 1.0 Soy isoflavone 0.5 Isohexadecane 3.0 Isopropyl isostearate 0.5 Cetyl alcohol 0.3 Stearyl alcohol 0.35 Behenyl alcohol 0.3 PEG-100stearate 0.1 Cetearyl glucoside 0.1 Sodium acrylate/sodium acryloyldimethyi taurate copolymer/isohexadecane/Polysorbate 80 3.0 Dimethicone/dimethiconol 1.0 Polymethylsilsequioxane 0.5 Timiron Splendid Red3 1.0 75% aqueous titanium dioxide dispersion (available from Kobo). 2 Palmitoyi-lysine-threonine-threonine-lysine-serine (available from SedermaX 3 Sifica and titanium dioxide coated mica red interference pigment (available from Rona). 5 EXAMPLE 14 Illustrated herein is a moisturizing water-in-silicone cream/lotion formulated with the ingredients listed under table XIII TABLE Xitl INGREDIENT WEIGHT % Water Balance Quaternary ammonium trihydroxydipropylethersalt of example 1a 0.5 Allantoin 0.2 Disodium EDTA 0.1 Ethyl paraben 0.2 Propyl paraben 0.1 Caffeine 1.0 BHT 0.1 21 WO 2007/101527 PCT/EP2007/001297 Dexpanthenol 0.5 Glycerin 10.0 Niacinamide 2.0 Palmitoyl-pentapeptide1 0.0003 GLW75CAP-MP2 0.5 Tlmiron Splendid Red3 1.0 Palmitoyl-lysine-threonine-threonine-lysine-serine (available from Sederma). 2 75% aqueous titanium dioxide dispersion (available from Kobo). 3 Silica and titanium dioxide coated mica red interference pigment (available from Rona). 22 WO 2007/101527 PCT/EP2007/001297 CLAIMS 1. A personal care composition comprising: (i) from 0.0000001 to 10% by weight of a quatemized ammonium trihydroxy 5 dipropyl ether selected from the group consisting of formula (I), (II) and mixtures thereof wherein R is the same or different C13 alkyl or hydroxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion; and wherein R is the same or different C1-3 alkyl or hydroxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion; and 10 (ii) a cosmetically acceptable earner. 2. The composition according to claim 1 wherein R is a methyl group. 3. The composition according to claim 1 wherein X* is chloride. 15 4. The composition according to claim 1 further comprising a 2,3-dihydroxypropyl trifC1-C3) quaternary ammonium salt. 5. The composition according to claim 4 wherein the ratio of quatemized ammonium 20 trihydroxy dipropylether to 2,3-dihydroxypropyl trifCrQj) quaternary ammonium salt ranges from 1; 1 to about 1:10,000 by weight. 6. The composition according to claim 5 wherein the ratio ranges from about 1:10 to about 1:5000 by weight 25 7. The composition according to claim 5 wherein the ratio ranges from about 1:100 to about 1:1000. 8. The composition according to claim 4 wherein the 2,3-dihydroxypropyl tri(C1-C3) 30 quaternary ammonium salt is 2,3-dihydroxypropyl trimethylarnmoniurn chloride. 9. A compound having the formula (I) or (II) 23 WO 2007/101527 PCT/EP2007/001297 wherein R is the same or different C1-C3 alkyl or hydraxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion. 10. A compound according to claim 9 wherein R is methyl and X" is chloride. HINDUSTAN UNILEVER LIMITED Dated this 28th day of August 2008

Documents:

1856-mumnp-2008 claims.pdf

1856-MUMNP-2008-ANNEXURE TO FORM 3(20-10-2008).pdf

1856-MUMNP-2008-ASSIGNMENT(28-8-2008).pdf

1856-MUMNP-2008-CLAIMS(28-8-2008).pdf

1856-MUMNP-2008-CLAIMS(AMENDED)-(22-7-2013).pdf

1856-MUMNP-2008-CLAIMS(AMENDED)-(31-7-2013).pdf

1856-MUMNP-2008-CLAIMS(MARKED COPY)-(22-7-2013).pdf

1856-MUMNP-2008-CLAIMS(MARKED COPY)-(31-7-2013).pdf

1856-mumnp-2008-claims.doc

1856-mumnp-2008-correspondance.pdf

1856-MUMNP-2008-CORRESPONDENCE(10-6-2013).pdf

1856-MUMNP-2008-CORRESPONDENCE(11-1-2013).pdf

1856-MUMNP-2008-CORRESPONDENCE(20-10-2008).pdf

1856-MUMNP-2008-CORRESPONDENCE(27-11-2009).pdf

1856-MUMNP-2008-CORRESPONDENCE(28-8-2008).pdf

1856-MUMNP-2008-CORRESPONDENCE(3-12-2012).pdf

1856-MUMNP-2008-CORRESPONDENCE(31-7-2013).pdf

1856-MUMNP-2008-CORRESPONDENCE(9-6-2010).pdf

1856-MUMNP-2008-DESCRIPTION(COMPLETE)-(28-8-2008).pdf

1856-mumnp-2008-description(complete).doc

1856-mumnp-2008-description(complete).pdf

1856-MUMNP-2008-EXAMINATION REPORT REPLY(26-3-2012).pdf

1856-MUMNP-2008-FOREIGN FILINGS CORRESPONDENCE(20-10-2008).pdf

1856-mumnp-2008-form 1.pdf

1856-MUMNP-2008-FORM 13(7-2-2012).pdf

1856-MUMNP-2008-FORM 18(27-11-2009).pdf

1856-MUMNP-2008-FORM 2(COMPLETE)-(28-8-2008).pdf

1856-MUMNP-2008-FORM 2(TITLE PAGE)-(28-8-2008).pdf

1856-mumnp-2008-form 2(title page).pdf

1856-mumnp-2008-form 2.doc

1856-mumnp-2008-form 2.pdf

1856-MUMNP-2008-FORM 3(12-8-2011).pdf

1856-MUMNP-2008-FORM 3(15-2-2011).pdf

1856-MUMNP-2008-FORM 3(15-2-2012).pdf

1856-MUMNP-2008-FORM 3(22-6-2013).pdf

1856-MUMNP-2008-FORM 3(23-1-2013).pdf

1856-MUMNP-2008-FORM 3(24-2-2010).pdf

1856-MUMNP-2008-FORM 3(26-3-2012).pdf

1856-MUMNP-2008-FORM 3(28-8-2008).pdf

1856-MUMNP-2008-FORM 3(4-8-2010).pdf

1856-MUMNP-2008-FORM 3(8-8-2012).pdf

1856-mumnp-2008-form 3.pdf

1856-mumnp-2008-form 5..pdf

1856-mumnp-2008-form pct isa 210.pdf

1856-mumnp-2008-form pct-ipea-416.pdf

1856-mumnp-2008-form-pct-ipea-409.pdf

1856-MUMNP-2008-GENERAL POWER OF ATTORNEY(28-8-2008).pdf

1856-MUMNP-2008-OTHER DOCUMENT(20-10-2008).pdf

1856-MUMNP-2008-OTHER DOCUMENT(22-7-2013).pdf

1856-MUMNP-2008-PETITION UNDER RULE-137(22-7-2013).pdf

1856-MUMNP-2008-POWER OF ATTORNEY(22-7-2013).pdf

1856-mumnp-2008-power of attorney.pdf

1856-MUMNP-2008-REPLY TO EXAMINATION REPORT(3-5-2012).pdf

1856-MUMNP-2008-REPLY TO HEARING(22-7-2013).pdf

1856-MUMNP-2008-US DOCUMENTS(26-3-2012).pdf

1856-mumnp-2008-wo-international publication report a1.pdf